this biotech double its price again? 7:02 a.m. Jul
Post# of 144494
Posted On: 11/12/2013 5:50:49 PM
this biotech double its price again? 7:02 a.m. July 17, 2013 - The Trading Deck
This is a market that wants to go up 12:32 p.m. July 9, 2013 - The Trading Deck
For the medium-term trader, setups galore 10:39 a.m. May 14, 2013 - The Trading Deck
Transparency: Filings reveal funds like Lululemon 11:22 a.m. April 17, 2013 - Insider Monkey
S&P 500 retests the breakout point 10:01 a.m. April 15, 2013 - Michael Ashbaugh
Slow-motion uptrend nears major resistance 10:12 a.m. March 13, 2013 - Michael Ashbaugh
Nasdaq clues suggest more upward valuation 12:46 p.m. March 8, 2013 - The Trading Deck
Stocks poised to top all-time closing high 9:23 a.m. March 5, 2013 - Kate Gibson
J.C. Penney, Impax shares drop after hours 6:46 p.m. March 4, 2013 - Carla Mozee
Santarus Q4 profit triples, offers upbeat view 5:50 p.m. March 4, 2013 - MarketWatch.com
Santarus shares resume trading, rise 12% 4:38 p.m. March 4, 2013 - Carla Mozee
13 stocks for ’13 6:16 p.m. Jan. 3, 2013 - The Trading Deck
Hot stocks to watch 6:31 a.m. Sept. 12, 2012 - MarketWatch.com
U.S. benchmarks violate the 200-day average 10:06 a.m. June 4, 2012 - Michael Ashbaugh
Stocks to watch Monday: AIG, AMD, BP 6:36 a.m. March 5, 2012 - MarketWatch
Medicis, PDL lead drug stocks north 11:47 a.m. Feb. 28, 2011 - Val Brickates Kennedy
Santarus, Pharming tumble on FDA setback 10:11 a.m. Feb. 28, 2011 - Val Brickates Kennedy
Drug indexes diverge; BioSante falls 1:00 p.m. Dec. 28, 2010 - Val Brickates Kennedy
Infinity Shares Up, Post Narrower Loss - Analyst Blog 2:40 p.m. Today - Zacks.com
Shire Buying ViroPharma To Rule Rare Disease Market 4:18 p.m. Nov. 11, 2013 - Investors Business Daily
ViroPharma Gets Bought Out; Medicines Clears Entry 4:13 p.m. Nov. 11, 2013 - Investors Business Daily
Salix Pharmaceuticals - Fresh Highs On The Santaurus Deal 3:03 p.m. Nov. 11, 2013 - Seeking Alpha
Shire Acquiring ViroPharma; Both Stocks Hit Highs 9:57 a.m. Nov. 11, 2013 - Investors Business Daily
Santarus (SNTS) Catches Eye: Stock Surges 37.6% - Analyst Blog 9:14 a.m. Nov. 11, 2013 - Zacks.com
What Does Salix Really Want With Santarus, And Should You Buy? 3:27 a.m. Nov. 11, 2013 - Seeking Alpha
Salix Pharmaceuticals: Santarus Acquisition Fortifies Position In Maturing Gastrointestinal Therapeutics Market 1:42 a.m. Nov. 11, 2013 - Seeking Alpha
BofA Executive Nominated for Under Secretary Of Commerce and 2 Other Hot Stocks to Watch 11:47 a.m. Nov. 8, 2013 - Wall St. Cheat Sheet
Salix Misses On Q3 Earnings; To Buy Santarus - Analyst Blog 11:30 a.m. Nov. 8, 2013 - Zacks.com
The Deal: Salix Pharmaceuticals Buys Santarus for $2.6B 10:50 a.m. Nov. 8, 2013 - TheStreet.com
Santarus (SNTS): Heavy Pre-Market Activity 8:28 a.m. Nov. 8, 2013 - TheStreet.com
UPDATE: Piper Jaffray Downgrades Santarus Following Salix Acquisition Announcement 8:16 a.m. Nov. 8, 2013 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:08 a.m. Nov. 8, 2013 - benzinga.com
Benzinga's Top Downgrades 6:17 a.m. Nov. 8, 2013 - benzinga.com
Santarus Pharming, Announce New Data from Open-Label Repeat Treatment Study with RUCONEST 4:55 a.m. Nov. 8, 2013 - benzinga.com
Salix Pharma to Acquire Santarus 6:18 p.m. Nov. 7, 2013 - TheStreet.com
Salix, Santarus Merging Into Billion-Dollar Drugmaker 5:38 p.m. Nov. 7, 2013 - Investors Business Daily
10-Q: SANTARUS INC 4:39 p.m. Nov. 7, 2013 - Edgar Online - (EDG = 10Q, 10K)
Santarus Earnings Should Top 4 Hot Small-Cap Medicals 7:02 a.m. Nov. 7, 2013 - Investors Business Daily
Biotechnology Companies' Quarterly Results - Research Report on Geron, Santarus, Merrimack, Clovis, and Arena 8:00 a.m. Today - PR Newswire
Morgan & Morgan Announces the Investigation of Santarus, Inc. 4:15 p.m. Nov. 11, 2013 - PR Newswire
SANTARUS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 12:31 p.m. Nov. 11, 2013 - BusinessWire
Ryan & Maniskas, LLP Announces Investigation of Santarus, Inc. 11:31 a.m. Nov. 11, 2013 - PR Newswire
Harwood Feffer LLP Announces Investigation of Santarus, Inc. 9:10 p.m. Nov. 8, 2013 - PR Newswire
Santarus, Inc. and Salix Pharmaceuticals, Ltd. Merger May Not Be in Santarus, Inc. Shareholders' Best Interests 4:36 p.m. Nov. 8, 2013 - PR Newswire
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Santarus, Inc. Stockholders 4:24 p.m. Nov. 8, 2013 - BusinessWire
Law Offices of Howard G. Smith Announces Investigation of Santarus Inc. 1:38 p.m. Nov. 8, 2013 - BusinessWire
Wolf Haldenstein Announces Investigation of Acquisition of Santarus, Inc. 12:36 p.m. Nov. 8, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Santarus, Inc. - SNTS 12:35 p.m. Nov. 8, 2013 - PR Newswire
Santarus Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Salix Pharma 11:32 a.m. Nov. 8, 2013 - BusinessWire
SANTARUS SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Santarus, Inc. (SNTS) Over the Proposed Sale of the Company to Salix Pharmaceuticals Ltd. (SLXP) 11:12 a.m. Nov. 8, 2013 - BusinessWire
Finkelstein Thompson LLP Announces Investigation of Santarus, Inc. Buyout Proposal 10:52 a.m. Nov. 8, 2013 - BusinessWire
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of the Santarus, Inc. Proposed Acquisition by Salix Pharmaceuticals, Ltd. 10:34 a.m. Nov. 8, 2013 - BusinessWire
SANTARUS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:33 a.m. Nov. 8, 2013 - BusinessWire
Santarus, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Salix Pharmaceuticals, Ltd. 10:17 a.m. Nov. 8, 2013 - PR Newswire
Law Firm Brower Piven Announces Investigation of Santarus, Inc. Proposed Buyout 9:57 a.m. Nov. 8, 2013 - BusinessWire
LEVI & KORSINSKY, LLP Notifies Investors of SANTARUS, INC. of Claims of Breaches of Fiduciary Duty by Board of the Company in Connection with Sale of the Company to Salix Pharmaceuticals, Ltd. 7:18 a.m. Nov. 8, 2013 - BusinessWire
PHARMING AND SANTARUS ANNOUNCE NEW DATA FROM OPEN-LABEL REPEAT TREATMENT STUDY WITH RUCONEST 1:00 a.m. Nov. 8, 2013 - Thomson Reuters ONE
Santarus and Pharming Announce New Data from Open-Label Repeat Treatment Study with RUCONEST (Recombinant Human C1 Esterase Inhibitor) 1:00 a.m. Nov. 8, 2013 - BusinessWire
$SNTS Company News
BHP as an example against contrarian investing 8:42 a.m. Aug. 20, 2013 - The Trading Deck
4 small caps set to surge 10:29 a.m. July 24, 2013 - The Trading Deck
Can
This is a market that wants to go up 12:32 p.m. July 9, 2013 - The Trading Deck
For the medium-term trader, setups galore 10:39 a.m. May 14, 2013 - The Trading Deck
Transparency: Filings reveal funds like Lululemon 11:22 a.m. April 17, 2013 - Insider Monkey
S&P 500 retests the breakout point 10:01 a.m. April 15, 2013 - Michael Ashbaugh
Slow-motion uptrend nears major resistance 10:12 a.m. March 13, 2013 - Michael Ashbaugh
Nasdaq clues suggest more upward valuation 12:46 p.m. March 8, 2013 - The Trading Deck
Stocks poised to top all-time closing high 9:23 a.m. March 5, 2013 - Kate Gibson
J.C. Penney, Impax shares drop after hours 6:46 p.m. March 4, 2013 - Carla Mozee
Santarus Q4 profit triples, offers upbeat view 5:50 p.m. March 4, 2013 - MarketWatch.com
Santarus shares resume trading, rise 12% 4:38 p.m. March 4, 2013 - Carla Mozee
13 stocks for ’13 6:16 p.m. Jan. 3, 2013 - The Trading Deck
Hot stocks to watch 6:31 a.m. Sept. 12, 2012 - MarketWatch.com
U.S. benchmarks violate the 200-day average 10:06 a.m. June 4, 2012 - Michael Ashbaugh
Stocks to watch Monday: AIG, AMD, BP 6:36 a.m. March 5, 2012 - MarketWatch
Medicis, PDL lead drug stocks north 11:47 a.m. Feb. 28, 2011 - Val Brickates Kennedy
Santarus, Pharming tumble on FDA setback 10:11 a.m. Feb. 28, 2011 - Val Brickates Kennedy
Drug indexes diverge; BioSante falls 1:00 p.m. Dec. 28, 2010 - Val Brickates Kennedy
Infinity Shares Up, Post Narrower Loss - Analyst Blog 2:40 p.m. Today - Zacks.com
Shire Buying ViroPharma To Rule Rare Disease Market 4:18 p.m. Nov. 11, 2013 - Investors Business Daily
ViroPharma Gets Bought Out; Medicines Clears Entry 4:13 p.m. Nov. 11, 2013 - Investors Business Daily
Salix Pharmaceuticals - Fresh Highs On The Santaurus Deal 3:03 p.m. Nov. 11, 2013 - Seeking Alpha
Shire Acquiring ViroPharma; Both Stocks Hit Highs 9:57 a.m. Nov. 11, 2013 - Investors Business Daily
Santarus (SNTS) Catches Eye: Stock Surges 37.6% - Analyst Blog 9:14 a.m. Nov. 11, 2013 - Zacks.com
What Does Salix Really Want With Santarus, And Should You Buy? 3:27 a.m. Nov. 11, 2013 - Seeking Alpha
Salix Pharmaceuticals: Santarus Acquisition Fortifies Position In Maturing Gastrointestinal Therapeutics Market 1:42 a.m. Nov. 11, 2013 - Seeking Alpha
BofA Executive Nominated for Under Secretary Of Commerce and 2 Other Hot Stocks to Watch 11:47 a.m. Nov. 8, 2013 - Wall St. Cheat Sheet
Salix Misses On Q3 Earnings; To Buy Santarus - Analyst Blog 11:30 a.m. Nov. 8, 2013 - Zacks.com
The Deal: Salix Pharmaceuticals Buys Santarus for $2.6B 10:50 a.m. Nov. 8, 2013 - TheStreet.com
Santarus (SNTS): Heavy Pre-Market Activity 8:28 a.m. Nov. 8, 2013 - TheStreet.com
UPDATE: Piper Jaffray Downgrades Santarus Following Salix Acquisition Announcement 8:16 a.m. Nov. 8, 2013 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:08 a.m. Nov. 8, 2013 - benzinga.com
Benzinga's Top Downgrades 6:17 a.m. Nov. 8, 2013 - benzinga.com
Santarus Pharming, Announce New Data from Open-Label Repeat Treatment Study with RUCONEST 4:55 a.m. Nov. 8, 2013 - benzinga.com
Salix Pharma to Acquire Santarus 6:18 p.m. Nov. 7, 2013 - TheStreet.com
Salix, Santarus Merging Into Billion-Dollar Drugmaker 5:38 p.m. Nov. 7, 2013 - Investors Business Daily
10-Q: SANTARUS INC 4:39 p.m. Nov. 7, 2013 - Edgar Online - (EDG = 10Q, 10K)
Santarus Earnings Should Top 4 Hot Small-Cap Medicals 7:02 a.m. Nov. 7, 2013 - Investors Business Daily
Biotechnology Companies' Quarterly Results - Research Report on Geron, Santarus, Merrimack, Clovis, and Arena 8:00 a.m. Today - PR Newswire
Morgan & Morgan Announces the Investigation of Santarus, Inc. 4:15 p.m. Nov. 11, 2013 - PR Newswire
SANTARUS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 12:31 p.m. Nov. 11, 2013 - BusinessWire
Ryan & Maniskas, LLP Announces Investigation of Santarus, Inc. 11:31 a.m. Nov. 11, 2013 - PR Newswire
Harwood Feffer LLP Announces Investigation of Santarus, Inc. 9:10 p.m. Nov. 8, 2013 - PR Newswire
Santarus, Inc. and Salix Pharmaceuticals, Ltd. Merger May Not Be in Santarus, Inc. Shareholders' Best Interests 4:36 p.m. Nov. 8, 2013 - PR Newswire
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Santarus, Inc. Stockholders 4:24 p.m. Nov. 8, 2013 - BusinessWire
Law Offices of Howard G. Smith Announces Investigation of Santarus Inc. 1:38 p.m. Nov. 8, 2013 - BusinessWire
Wolf Haldenstein Announces Investigation of Acquisition of Santarus, Inc. 12:36 p.m. Nov. 8, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Santarus, Inc. - SNTS 12:35 p.m. Nov. 8, 2013 - PR Newswire
Santarus Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Salix Pharma 11:32 a.m. Nov. 8, 2013 - BusinessWire
SANTARUS SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Santarus, Inc. (SNTS) Over the Proposed Sale of the Company to Salix Pharmaceuticals Ltd. (SLXP) 11:12 a.m. Nov. 8, 2013 - BusinessWire
Finkelstein Thompson LLP Announces Investigation of Santarus, Inc. Buyout Proposal 10:52 a.m. Nov. 8, 2013 - BusinessWire
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of the Santarus, Inc. Proposed Acquisition by Salix Pharmaceuticals, Ltd. 10:34 a.m. Nov. 8, 2013 - BusinessWire
SANTARUS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:33 a.m. Nov. 8, 2013 - BusinessWire
Santarus, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Salix Pharmaceuticals, Ltd. 10:17 a.m. Nov. 8, 2013 - PR Newswire
Law Firm Brower Piven Announces Investigation of Santarus, Inc. Proposed Buyout 9:57 a.m. Nov. 8, 2013 - BusinessWire
LEVI & KORSINSKY, LLP Notifies Investors of SANTARUS, INC. of Claims of Breaches of Fiduciary Duty by Board of the Company in Connection with Sale of the Company to Salix Pharmaceuticals, Ltd. 7:18 a.m. Nov. 8, 2013 - BusinessWire
PHARMING AND SANTARUS ANNOUNCE NEW DATA FROM OPEN-LABEL REPEAT TREATMENT STUDY WITH RUCONEST 1:00 a.m. Nov. 8, 2013 - Thomson Reuters ONE
Santarus and Pharming Announce New Data from Open-Label Repeat Treatment Study with RUCONEST (Recombinant Human C1 Esterase Inhibitor) 1:00 a.m. Nov. 8, 2013 - BusinessWire
$SNTS Company News
BHP as an example against contrarian investing 8:42 a.m. Aug. 20, 2013 - The Trading Deck
4 small caps set to surge 10:29 a.m. July 24, 2013 - The Trading Deck
Can
(0)
(0)Scroll down for more posts ▼